LOSARTAN POTASSIUM

LOSARTAN POTASSIUM was reported 80158 times

LOSARTAN POTASSIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARDIOSPASM 60 0.1075
1 PALMOPLANTAR KERATODERMA 61 0.0841
2 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 67 0.0631
3 NEPHROGENIC ANAEMIA 240 0.0518
4 HYPERPARATHYROIDISM SECONDARY 126 0.0502
5 ESSENTIAL HYPERTENSION 91 0.0497
6 EYELID PAIN 85 0.0418
7 ATRIAL TACHYCARDIA 85 0.0404
8 PRURITUS GENITAL 82 0.0348
9 INFUSION SITE DISCHARGE 51 0.0291
10 REBOUND ACID HYPERSECRETION 87 0.0287
11 BLOOD PRESSURE INADEQUATELY CONTROLLED 163 0.0271
12 NEPHROGENIC SYSTEMIC FIBROSIS 80 0.0264
13 CAROTID ARTERY OCCLUSION 93 0.0255
14 ISCHAEMIC CARDIOMYOPATHY 71 0.0231
15 END STAGE RENAL DISEASE 411 0.0225
16 ANGINA UNSTABLE 143 0.0220
17 RENAL FAILURE CHRONIC 166 0.0216
18 SKIN HYPERTROPHY 60 0.0213
19 BUNDLE BRANCH BLOCK LEFT 87 0.0205
20 ORTHOPNOEA 65 0.0204
21 AORTIC ARTERIOSCLEROSIS 51 0.0198
22 AORTIC STENOSIS 69 0.0198
23 INFUSION SITE HAEMORRHAGE 64 0.0194
24 LEFT VENTRICULAR HYPERTROPHY 83 0.0194
25 TENSION HEADACHE 83 0.0193
26 SEASONAL ALLERGY 270 0.0191
27 PRE-EXISTING CONDITION IMPROVED 118 0.0189
28 DIVERTICULUM INTESTINAL 82 0.0187
29 DIABETIC NEUROPATHY 91 0.0184
30 SUSPECTED SUICIDE 86 0.0183
31 HAEMORRHAGIC ANAEMIA 80 0.0182
32 INFUSION SITE PRURITUS 57 0.0180
33 HYPERLIPIDAEMIA 214 0.0179
34 MITRAL VALVE INCOMPETENCE 197 0.0174
35 TRICUSPID VALVE INCOMPETENCE 137 0.0172
36 LOSS OF EMPLOYMENT 52 0.0172
37 PRODUCT ADMINISTRATION INTERRUPTED 134 0.0171
38 CAROTID ARTERY STENOSIS 58 0.0166
39 BENIGN PROSTATIC HYPERPLASIA 85 0.0164
40 SLEEP TERROR 69 0.0164
41 CARDIOMEGALY 201 0.0163
42 SLEEP APNOEA SYNDROME 311 0.0163
43 BLOOD PRESSURE ABNORMAL 320 0.0161
44 CHRONIC KIDNEY DISEASE 1215 0.0160
45 ARTERIOSCLEROSIS CORONARY ARTERY 105 0.0158
46 MULTIPLE ALLERGIES 124 0.0158
47 CORONARY ARTERY STENOSIS 79 0.0157
48 DIVERTICULUM 111 0.0156
49 RHINITIS ALLERGIC 69 0.0155
50 UPPER-AIRWAY COUGH SYNDROME 127 0.0154
51 OLIGOHYDRAMNIOS 51 0.0153
52 AORTIC VALVE INCOMPETENCE 64 0.0150
53 HEPATIC CYST 51 0.0150
54 CORONARY ARTERY DISEASE 449 0.0148
55 ATRIOVENTRICULAR BLOCK FIRST DEGREE 64 0.0147
56 BODY HEIGHT DECREASED 157 0.0147
57 RENAL CYST 115 0.0145
58 CARDIAC FAILURE CONGESTIVE 1161 0.0144
59 EYE PAIN 807 0.0143
60 DIABETIC RETINOPATHY 48 0.0141
61 SPINAL OSTEOARTHRITIS 122 0.0139
62 CHRONIC SINUSITIS 52 0.0138
63 INFUSION SITE SWELLING 87 0.0138
64 PERIPHERAL VASCULAR DISORDER 71 0.0138
65 HIATUS HERNIA 177 0.0137
66 HAEMOGLOBIN INCREASED 62 0.0136
67 RENAL FAILURE ACUTE 575 0.0135
68 BLOOD UREA INCREASED 226 0.0135
69 ARTERIOSCLEROSIS 127 0.0135
70 SNORING 51 0.0135
71 FACIAL PAIN 120 0.0134
72 BLOOD PRESSURE INCREASED 2052 0.0134
73 RALES 77 0.0132
74 INTERVERTEBRAL DISC DEGENERATION 122 0.0132
75 HYPERKALAEMIA 462 0.0132
76 HYPOVOLAEMIA 77 0.0131
77 PARANASAL SINUS HYPERSECRETION 50 0.0131
78 BLOOD MAGNESIUM DECREASED 113 0.0131
79 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 220 0.0129
80 DIZZINESS POSTURAL 125 0.0129
81 BLOOD POTASSIUM INCREASED 208 0.0128
82 BLOOD SODIUM DECREASED 240 0.0127
83 TONGUE DISCOMFORT 54 0.0127
84 HYPERKERATOSIS 70 0.0127
85 INTERVERTEBRAL DISC DISORDER 54 0.0126
86 DYSLIPIDAEMIA 64 0.0126
87 HYPERTENSIVE CRISIS 139 0.0125
88 HAEMORRHOIDAL HAEMORRHAGE 61 0.0125
89 GOUT 224 0.0125
90 CARDIAC VALVE DISEASE 71 0.0124
91 FOREIGN BODY SENSATION IN EYES 79 0.0124
92 CARDIAC MURMUR 107 0.0124
93 NOCTURIA 150 0.0123
94 DYSPNOEA EXERTIONAL 465 0.0123
95 TRANSIENT ISCHAEMIC ATTACK 415 0.0123
96 VENTRICULAR EXTRASYSTOLES 127 0.0122
97 HEPATIC STEATOSIS 226 0.0121
98 STOMACH DISCOMFORT 62 0.0120
99 VITAMIN D DEFICIENCY 117 0.0120
100 ONYCHOMYCOSIS 52 0.0118
101 CORONARY ARTERY OCCLUSION 162 0.0118
102 IRON DEFICIENCY ANAEMIA 109 0.0118
103 VENTRICULAR TACHYCARDIA 194 0.0117
104 SPINAL COLUMN STENOSIS 55 0.0116
105 ACUTE MYOCARDIAL INFARCTION 342 0.0116
106 BUNDLE BRANCH BLOCK RIGHT 53 0.0115
107 STENT PLACEMENT 93 0.0115
108 ECCHYMOSIS 79 0.0115
109 PRODUCT DOSE OMISSION IN ERROR 325 0.0115
110 RENAL INJURY 340 0.0114
111 CHOKING SENSATION 63 0.0114
112 EYE INFECTION 129 0.0114
113 ORAL PAIN 255 0.0114
114 ECONOMIC PROBLEM 172 0.0113
115 ARTERIAL OCCLUSIVE DISEASE 89 0.0113
116 GINGIVAL SWELLING 50 0.0113
117 HYPERTENSION 2387 0.0113
118 BLOOD PRESSURE FLUCTUATION 270 0.0112
119 NEPHROPATHY 105 0.0112
120 OCULAR DISCOMFORT 126 0.0112
121 BLOOD POTASSIUM DECREASED 337 0.0112
122 HEART RATE IRREGULAR 253 0.0112
123 PULMONARY HYPERTENSION 233 0.0112
124 INFUSION SITE PAIN 144 0.0112
125 RENAL FAILURE 1481 0.0111
126 INFUSION SITE ERYTHEMA 94 0.0111
127 PRODUCTIVE COUGH 531 0.0111
128 CARDIAC PACEMAKER INSERTION 66 0.0111
129 BURSITIS 134 0.0110
130 CARDIAC FLUTTER 71 0.0110
131 ATRIAL FLUTTER 87 0.0109
132 SCIATICA 173 0.0108
133 GLUCOSE TOLERANCE IMPAIRED 64 0.0108
134 MYOCARDIAL ISCHAEMIA 123 0.0108
135 TOOTH ABSCESS 110 0.0108
136 ANGINA PECTORIS 309 0.0108
137 NERVE COMPRESSION 99 0.0107
138 DRY THROAT 109 0.0107
139 ATRIAL FIBRILLATION 1044 0.0107
140 GROIN PAIN 94 0.0107
141 HAEMORRHOIDS 208 0.0107
142 GLOMERULAR FILTRATION RATE DECREASED 131 0.0106
143 SINUS DISORDER 211 0.0106
144 HAEMORRHAGIC STROKE 83 0.0106
145 FULL BLOOD COUNT DECREASED 214 0.0106
146 CORONARY ARTERY BYPASS 61 0.0106
147 ELECTROCARDIOGRAM ABNORMAL 83 0.0106
148 ORTHOSTATIC HYPOTENSION 184 0.0106
149 BREATH SOUNDS ABNORMAL 52 0.0105
150 BLOOD CALCIUM INCREASED 92 0.0105
151 SKIN FISSURES 205 0.0105
152 ANEURYSM 52 0.0104
153 ROTATOR CUFF SYNDROME 134 0.0104
154 INCREASED TENDENCY TO BRUISE 96 0.0104
155 SKIN TIGHTNESS 49 0.0104
156 IMPAIRED QUALITY OF LIFE 149 0.0104
157 ATELECTASIS 100 0.0103
158 COUGH 2878 0.0103
159 CORONARY ARTERIAL STENT INSERTION 52 0.0102
160 LIMB OPERATION 49 0.0102
161 SUBARACHNOID HAEMORRHAGE 104 0.0102
162 BLOOD CHOLESTEROL ABNORMAL 47 0.0102
163 RHINITIS 82 0.0102
164 MUSCULOSKELETAL DISCOMFORT 175 0.0102
165 LEFT VENTRICULAR DYSFUNCTION 68 0.0101
166 RED BLOOD CELL COUNT DECREASED 289 0.0101
167 RENAL TUBULAR NECROSIS 99 0.0101
168 OEDEMA PERIPHERAL 1225 0.0100
169 PROTEIN URINE PRESENT 50 0.0100
170 SINUS CONGESTION 135 0.0100
171 BLOOD CREATININE INCREASED 650 0.0099
172 BLOOD IRON DECREASED 118 0.0099
173 HAEMATOCRIT DECREASED 197 0.0099
174 ONYCHOCLASIS 68 0.0099
175 AGEUSIA 246 0.0099
176 CARPAL TUNNEL SYNDROME 138 0.0098
177 EMPHYSEMA 99 0.0098
178 OSTEOARTHRITIS 415 0.0098
179 OSTEOPENIA 148 0.0097
180 EAR DISCOMFORT 100 0.0097
181 EYE HAEMORRHAGE 130 0.0097
182 BLOOD CHOLESTEROL INCREASED 454 0.0097
183 HOSPICE CARE 96 0.0097
184 CEREBRAL ISCHAEMIA 50 0.0097
185 FOOT OPERATION 48 0.0097
186 ACIDOSIS 74 0.0097
187 THYROID DISORDER 149 0.0097
188 EXOSTOSIS 88 0.0096
189 BRONCHITIS 712 0.0096
190 GASTROOESOPHAGEAL REFLUX DISEASE 769 0.0095
191 RENAL DISORDER 445 0.0095
192 EYE DISCHARGE 99 0.0095
193 ANURIA 82 0.0095
194 SINUSITIS 975 0.0095
195 BLOOD PRESSURE DECREASED 632 0.0095
196 EYE PRURITUS 317 0.0094
197 GASTRITIS 248 0.0094
198 FLANK PAIN 88 0.0094
199 DRY EYE 468 0.0094
200 VASCULITIS 109 0.0093
201 SPINAL OPERATION 115 0.0093
202 DECREASED INTEREST 55 0.0093
203 SLUGGISHNESS 95 0.0093
204 POLLAKIURIA 387 0.0093
205 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 483 0.0092
206 DIABETES MELLITUS 705 0.0092
207 ODYNOPHAGIA 55 0.0092
208 CARDIOMYOPATHY 136 0.0092
209 RESPIRATORY TRACT CONGESTION 146 0.0092
210 MUSCULOSKELETAL CHEST PAIN 142 0.0092
211 CATARACT 546 0.0092
212 POLYURIA 75 0.0091
213 MUSCLE STRAIN 79 0.0091
214 BLOOD PRESSURE SYSTOLIC INCREASED 178 0.0091
215 PERIPHERAL SWELLING 1403 0.0091
216 FLUID RETENTION 463 0.0091
217 DYSPHONIA 532 0.0091
218 DIABETES MELLITUS INADEQUATE CONTROL 161 0.0091
219 HEART RATE DECREASED 319 0.0091
220 SWELLING OF EYELID 57 0.0091
221 SPINAL COMPRESSION FRACTURE 75 0.0091
222 ATRIOVENTRICULAR BLOCK 70 0.0090
223 PLATELET COUNT INCREASED 118 0.0090
224 SKIN HAEMORRHAGE 134 0.0090
225 INSURANCE ISSUE 138 0.0090
226 INTERNATIONAL NORMALISED RATIO INCREASED 257 0.0090
227 UPPER RESPIRATORY TRACT INFECTION 415 0.0090
228 BLOOD TRIGLYCERIDES INCREASED 158 0.0089
229 HAEMODIALYSIS 75 0.0089
230 LOW DENSITY LIPOPROTEIN INCREASED 69 0.0089
231 EXTRASYSTOLES 62 0.0089
232 PHOTOPHOBIA 167 0.0089
233 RENAL PAIN 94 0.0089
234 CYSTITIS 281 0.0088
235 URINARY TRACT INFECTION 1497 0.0088
236 GLAUCOMA 169 0.0088
237 INITIAL INSOMNIA 90 0.0088
238 DIVERTICULITIS 243 0.0088
239 HAIR COLOUR CHANGES 109 0.0088
240 SCRATCH 92 0.0087
241 DECREASED ACTIVITY 94 0.0087
242 CARDIAC FAILURE ACUTE 58 0.0087
243 LIGAMENT SPRAIN 86 0.0087
244 GINGIVAL PAIN 69 0.0087
245 GENERALISED OEDEMA 107 0.0086
246 NEPHROTIC SYNDROME 59 0.0086
247 HYPERCHOLESTEROLAEMIA 83 0.0086
248 ANKLE FRACTURE 133 0.0086
249 SKIN ULCER 222 0.0086
250 RESTLESS LEGS SYNDROME 156 0.0086
251 TASTE DISORDER 174 0.0086
252 MULTIPLE INJURIES 54 0.0086
253 SKIN DISCOLOURATION 394 0.0086
254 ANOSMIA 124 0.0086
255 CONSTIPATION 1866 0.0085
256 INTERVERTEBRAL DISC PROTRUSION 187 0.0085
257 DRY MOUTH 694 0.0085
258 ACUTE PULMONARY OEDEMA 48 0.0085
259 TENDERNESS 89 0.0085
260 TOOTH FRACTURE 94 0.0085
261 PULMONARY MASS 127 0.0085
262 BASAL CELL CARCINOMA 133 0.0085
263 SKIN ATROPHY 49 0.0085
264 URINARY INCONTINENCE 252 0.0085
265 WALKING AID USER 56 0.0085
266 EPISTAXIS 635 0.0085
267 PULMONARY OEDEMA 380 0.0085
268 NEPHROLITHIASIS 389 0.0085
269 PERICARDIAL EFFUSION 196 0.0085
270 COLITIS ISCHAEMIC 57 0.0084
271 RETCHING 180 0.0084
272 CHEST PAIN 1562 0.0084
273 LIMB INJURY 229 0.0084
274 CATARACT OPERATION 50 0.0084
275 JOINT EFFUSION 58 0.0084
276 LOWER GASTROINTESTINAL HAEMORRHAGE 62 0.0084
277 UPPER GASTROINTESTINAL HAEMORRHAGE 141 0.0084
278 ATRIOVENTRICULAR BLOCK COMPLETE 56 0.0084
279 ARTHROPOD BITE 62 0.0084
280 BACK DISORDER 136 0.0084
281 IMPAIRED GASTRIC EMPTYING 114 0.0084
282 OBESITY 133 0.0083
283 DEHYDRATION 1112 0.0083
284 JOINT INJURY 178 0.0083
285 INFARCTION 57 0.0083
286 HEAD INJURY 263 0.0083
287 THIRST 148 0.0083
288 BACK PAIN 1922 0.0083
289 HYPONATRAEMIA 465 0.0082
290 SINUS HEADACHE 49 0.0082
291 HYPOGLYCAEMIA 400 0.0082
292 URINE OUTPUT DECREASED 72 0.0082
293 BRAIN FOG 129 0.0082
294 WEIGHT FLUCTUATION 86 0.0082
295 ACUTE KIDNEY INJURY 1247 0.0081
296 ANOREXIA 105 0.0081
297 ANHEDONIA 214 0.0081
298 HYPOMAGNESAEMIA 113 0.0081
299 RHINORRHOEA 524 0.0081
300 PROTEINURIA 154 0.0081
301 SNEEZING 181 0.0081
302 SKIN SWELLING 70 0.0081
303 BLADDER DISORDER 80 0.0080
304 DYSSTASIA 235 0.0080
305 MOUTH HAEMORRHAGE 59 0.0080
306 MACULAR DEGENERATION 96 0.0080
307 RIB FRACTURE 165 0.0080
308 TINNITUS 368 0.0080
309 DYSPEPSIA 787 0.0080
310 FALL 2661 0.0080
311 APPETITE DISORDER 53 0.0080
312 POST PROCEDURAL HAEMORRHAGE 93 0.0080
313 HOT FLUSH 602 0.0080
314 BALANCE DISORDER 690 0.0080
315 NASAL DRYNESS 50 0.0080
316 PRODUCT DISTRIBUTION ISSUE 74 0.0080
317 DIZZINESS 3977 0.0080
318 DIPLOPIA 207 0.0080
319 MENISCUS INJURY 49 0.0080
320 PULMONARY CONGESTION 105 0.0080
321 BLOOD GLUCOSE DECREASED 382 0.0079
322 POLYP 52 0.0079
323 HYPERGLYCAEMIA 289 0.0079
324 OSTEOPOROSIS 326 0.0079
325 EAR PAIN 154 0.0079
326 SPINAL DISORDER 75 0.0079
327 SCOLIOSIS 49 0.0079
328 SKIN LACERATION 86 0.0079
329 NEUROPATHY PERIPHERAL 751 0.0079
330 CONTUSION 760 0.0079
331 ASTHMA 892 0.0079
332 FLATULENCE 447 0.0079
333 MYOCARDIAL INFARCTION 1375 0.0079
334 CONCUSSION 61 0.0079
335 LACRIMATION INCREASED 238 0.0079
336 FOOT FRACTURE 149 0.0079
337 BOWEL MOVEMENT IRREGULARITY 60 0.0078
338 PELVIC FRACTURE 61 0.0078
339 HAEMATURIA 268 0.0078
340 LYMPHOEDEMA 54 0.0078
341 DERMATITIS CONTACT 89 0.0078
342 POOR QUALITY SLEEP 168 0.0078
343 SCAB 89 0.0078
344 HAEMOGLOBIN DECREASED 801 0.0078
345 DUODENAL ULCER 55 0.0078
346 NASAL CONGESTION 458 0.0078
347 GASTROINTESTINAL HAEMORRHAGE 651 0.0078
348 INTENTIONAL DOSE OMISSION 222 0.0078
349 ANAL INCONTINENCE 70 0.0078
350 INCONTINENCE 82 0.0077
351 LIMB DISCOMFORT 240 0.0077
352 THROAT IRRITATION 348 0.0077
353 MUSCULAR WEAKNESS 881 0.0077
354 EYE IRRITATION 446 0.0077
355 HYDRONEPHROSIS 58 0.0077
356 ACUTE RESPIRATORY FAILURE 149 0.0077
357 ABDOMINAL DISCOMFORT 1299 0.0077
358 DYSURIA 285 0.0077
359 KNEE ARTHROPLASTY 163 0.0077
360 HYPOTENSION 1550 0.0077
361 CELLULITIS 389 0.0077
362 ARTHRITIS 607 0.0077
363 MUSCLE SPASMS 1416 0.0077
364 DECREASED APPETITE 1790 0.0077
365 HEART RATE INCREASED 762 0.0077
366 BLOOD ALBUMIN DECREASED 61 0.0077
367 OESOPHAGITIS 84 0.0077
368 HAEMATOMA 199 0.0077
369 FATIGUE 5971 0.0077
370 APHONIA 107 0.0077
371 RECTAL HAEMORRHAGE 329 0.0077
372 RECALLED PRODUCT ADMINISTERED 73 0.0076
373 OEDEMA 415 0.0076
374 LARGE INTESTINE POLYP 53 0.0076
375 PALPITATIONS 895 0.0076
376 DYSPNOEA 4320 0.0076
377 KNEE OPERATION 75 0.0076
378 AORTIC ANEURYSM 58 0.0076
379 TROPONIN INCREASED 58 0.0076
380 WEIGHT DECREASED 2123 0.0076
381 BLOOD URINE PRESENT 144 0.0076
382 BRONCHIECTASIS 51 0.0076
383 NERVE INJURY 84 0.0075
384 GINGIVAL BLEEDING 103 0.0075
385 MUSCLE DISORDER 61 0.0075
386 HYPOXIA 265 0.0075
387 PAIN IN JAW 213 0.0075
388 OXYGEN SATURATION DECREASED 422 0.0075
389 REFUSAL OF TREATMENT BY PATIENT 49 0.0075
390 ASTHENIA 2818 0.0075
391 GAIT DISTURBANCE 1434 0.0075
392 ELECTROLYTE IMBALANCE 87 0.0075
393 PROSTATIC SPECIFIC ANTIGEN INCREASED 103 0.0075
394 ARRHYTHMIA 354 0.0075
395 PAIN IN EXTREMITY 2197 0.0074
396 BREAST MASS 50 0.0074
397 ERUCTATION 144 0.0074
398 CHOLECYSTECTOMY 85 0.0074
399 CHOLELITHIASIS 244 0.0074
400 DIARRHOEA 4802 0.0074
401 FAECES DISCOLOURED 161 0.0074
402 OROPHARYNGEAL DISCOMFORT 67 0.0074
403 ESCHERICHIA INFECTION 61 0.0074
404 ANAEMIA 1414 0.0074
405 MYALGIA 1259 0.0074
406 LOCALISED INFECTION 179 0.0074
407 PLEURAL EFFUSION 449 0.0074
408 CARDIAC FAILURE 592 0.0074
409 VITAMIN D DECREASED 63 0.0074
410 TOOTH INFECTION 97 0.0074
411 STOMATITIS 446 0.0073
412 PULMONARY THROMBOSIS 80 0.0073
413 WHEEZING 435 0.0073
414 BLOOD GLUCOSE INCREASED 1379 0.0073
415 HAEMOPTYSIS 204 0.0073
416 OSTEOMYELITIS 132 0.0073
417 OROPHARYNGEAL PAIN 674 0.0073
418 ANGIOEDEMA 322 0.0073
419 HALLUCINATION 548 0.0073
420 MICTURITION URGENCY 83 0.0073
421 RESPIRATORY TRACT INFECTION 189 0.0072
422 POSTOPERATIVE WOUND INFECTION 49 0.0072
423 SLEEP DISORDER 511 0.0072
424 RENAL IMPAIRMENT 608 0.0072
425 VITREOUS FLOATERS 71 0.0072
426 MUSCLE TIGHTNESS 117 0.0072
427 VISION BLURRED 991 0.0072
428 BLOOD GLUCOSE FLUCTUATION 79 0.0072
429 CHEST DISCOMFORT 738 0.0072
430 BLOOD CALCIUM DECREASED 81 0.0072
431 JOINT DISLOCATION 76 0.0072
432 BLOOD COUNT ABNORMAL 109 0.0072
433 KIDNEY INFECTION 141 0.0072
434 NECK PAIN 401 0.0072
435 IRRITABLE BOWEL SYNDROME 153 0.0071
436 SKIN INFECTION 80 0.0071
437 HEAD DISCOMFORT 126 0.0071
438 MUSCLE ATROPHY 90 0.0071
439 ULCER HAEMORRHAGE 48 0.0071
440 JOINT RANGE OF MOTION DECREASED 95 0.0071
441 SYNCOPE 708 0.0071
442 TOOTHACHE 128 0.0071
443 PRODUCT DOSE OMISSION ISSUE 2078 0.0071
444 HIP FRACTURE 227 0.0071
445 SINUS BRADYCARDIA 68 0.0070
446 CARDIAC DISORDER 658 0.0070
447 WOUND INFECTION 77 0.0070
448 FLUSHING 713 0.0070
449 SCAR 120 0.0070
450 ILLNESS 722 0.0070
451 WRIST FRACTURE 84 0.0070
452 SPLENOMEGALY 82 0.0070
453 DYSGEUSIA 520 0.0070
454 SURGERY 410 0.0070
455 FEAR 188 0.0070
456 HERNIA 135 0.0070
457 TENDONITIS 108 0.0070
458 NAIL DISORDER 61 0.0070
459 TRANSFUSION 73 0.0070
460 EAR INFECTION 185 0.0069
461 ARTHRALGIA 2889 0.0069
462 FURUNCLE 55 0.0069
463 PNEUMOTHORAX 110 0.0069
464 LACERATION 65 0.0069
465 OCULAR HYPERAEMIA 328 0.0069
466 MUSCULOSKELETAL PAIN 362 0.0069
467 EATING DISORDER 147 0.0069
468 GLYCOSYLATED HAEMOGLOBIN INCREASED 174 0.0069
469 BLISTER 387 0.0069
470 DERMATITIS ATOPIC 363 0.0069
471 WHITE BLOOD CELL COUNT INCREASED 264 0.0069
472 GASTROENTERITIS VIRAL 124 0.0069
473 ABDOMINAL PAIN UPPER 1414 0.0069
474 CARDIAC OPERATION 59 0.0069
475 BONE DISORDER 125 0.0069
476 ABASIA 169 0.0068
477 GLOSSODYNIA 153 0.0068
478 TYPE 2 DIABETES MELLITUS 230 0.0068
479 PRURITUS 2623 0.0068
480 EJECTION FRACTION DECREASED 106 0.0068
481 PRODUCT SUBSTITUTION ISSUE 392 0.0068
482 HYPOKALAEMIA 314 0.0068
483 SQUAMOUS CELL CARCINOMA 64 0.0068
484 SECRETION DISCHARGE 85 0.0068
485 UPPER LIMB FRACTURE 135 0.0068
486 EYE SWELLING 252 0.0068
487 HYPERSOMNIA 194 0.0068
488 HERPES ZOSTER 387 0.0067
489 FEELING COLD 187 0.0067
490 ABDOMINAL DISTENSION 701 0.0067
491 MULTI-ORGAN FAILURE 116 0.0067
492 HICCUPS 55 0.0067
493 COLD SWEAT 118 0.0067
494 CEREBROVASCULAR ACCIDENT 1134 0.0067
495 LABORATORY TEST ABNORMAL 197 0.0067
496 FEELING JITTERY 127 0.0067
497 PNEUMONIA 2157 0.0067
498 DRY SKIN 887 0.0066
499 POST PROCEDURAL INFECTION 54 0.0066
500 SPINAL FRACTURE 133 0.0066
501 DECUBITUS ULCER 54 0.0066
502 DEAFNESS 173 0.0066
503 MALNUTRITION 74 0.0066
504 COVID-19 1160 0.0066
505 VIRAL INFECTION 220 0.0066
506 MEMORY IMPAIRMENT 908 0.0066
507 BURNING SENSATION 463 0.0066
508 MYOPATHY 57 0.0066
509 INFLUENZA 735 0.0066
510 NODULE 86 0.0066
511 MENTAL STATUS CHANGES 183 0.0066
512 SUPRAVENTRICULAR TACHYCARDIA 63 0.0066
513 HAIR TEXTURE ABNORMAL 88 0.0066
514 LUNG INFILTRATION 58 0.0066
515 SKIN DISORDER 219 0.0066
516 LOWER LIMB FRACTURE 126 0.0066
517 INSOMNIA 1746 0.0065
518 FEELING ABNORMAL 1568 0.0065
519 BRADYCARDIA 347 0.0065
520 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 314 0.0065
521 ACCIDENT 78 0.0065
522 BLOOD ALKALINE PHOSPHATASE INCREASED 162 0.0065
523 ACUTE CORONARY SYNDROME 54 0.0065
524 RASH PRURITIC 353 0.0065
525 PLATELET COUNT DECREASED 694 0.0065
526 DENTAL CARIES 72 0.0065
527 NERVOUSNESS 340 0.0065
528 EYE INFLAMMATION 62 0.0065
529 RASH MACULAR 227 0.0065
530 NIGHT SWEATS 209 0.0065
531 GASTRIC ULCER 123 0.0065
532 PYELONEPHRITIS 56 0.0065
533 HYPOPHAGIA 165 0.0064
534 FULL BLOOD COUNT ABNORMAL 68 0.0064
535 TOOTH EXTRACTION 80 0.0064
536 PRURITUS GENERALISED 139 0.0064
537 DEPRESSION 1462 0.0064
538 CLOSTRIDIUM DIFFICILE COLITIS 68 0.0064
539 FOOT DEFORMITY 71 0.0064
540 RHABDOMYOLYSIS 267 0.0064
541 VENTRICULAR FIBRILLATION 71 0.0064
542 NASOPHARYNGITIS 1178 0.0064
543 GASTRIC DISORDER 219 0.0064
544 FIBROMYALGIA 155 0.0064
545 POST PROCEDURAL COMPLICATION 122 0.0063
546 HYPERHIDROSIS 818 0.0063
547 PRODUCT USE COMPLAINT 100 0.0063
548 HALLUCINATION, VISUAL 134 0.0063
549 LIP SWELLING 211 0.0063
550 ORAL DISCOMFORT 88 0.0063
551 PETECHIAE 66 0.0063
552 SKIN LESION 173 0.0063
553 CHOKING 123 0.0063
554 GASTROENTERITIS 92 0.0063
555 HYPOAESTHESIA 942 0.0063
556 PRODUCT TASTE ABNORMAL 85 0.0063
557 DIALYSIS 89 0.0063
558 ERECTILE DYSFUNCTION 161 0.0063
559 BONE PAIN 367 0.0063
560 PERIPHERAL COLDNESS 86 0.0063
561 NEURALGIA 152 0.0062
562 SWELLING 585 0.0062
563 BLINDNESS UNILATERAL 88 0.0062
564 JOINT SWELLING 753 0.0062
565 MELAENA 137 0.0062
566 DYSPHAGIA 590 0.0062
567 UNEVALUABLE EVENT 470 0.0062
568 TEMPERATURE INTOLERANCE 64 0.0062
569 INTRAOCULAR PRESSURE INCREASED 79 0.0062
570 PHOTOSENSITIVITY REACTION 102 0.0062
571 HEADACHE 3867 0.0062
572 MIDDLE INSOMNIA 115 0.0062
573 FEELING HOT 377 0.0061
574 SHOCK HAEMORRHAGIC 50 0.0061
575 HYPOKINESIA 89 0.0061
576 WHITE BLOOD CELL COUNT DECREASED 664 0.0061
577 VERTIGO 373 0.0061
578 TORSADE DE POINTES 48 0.0061
579 LUNG DISORDER 299 0.0061
580 PANCREATITIS ACUTE 137 0.0061
581 IMPAIRED HEALING 200 0.0061
582 DEMENTIA 170 0.0061
583 BLOOD CREATINE PHOSPHOKINASE INCREASED 175 0.0061
584 HYPOTHYROIDISM 194 0.0061
585 HYPERCALCAEMIA 75 0.0061
586 MUSCLE TWITCHING 140 0.0061
587 HAIR DISORDER 50 0.0061
588 EYE DISORDER 199 0.0060
589 LOSS OF CONSCIOUSNESS 774 0.0060
590 TOOTH DISORDER 134 0.0060
591 MYOSITIS 54 0.0060
592 FEEDING DISORDER 122 0.0060
593 SPUTUM DISCOLOURED 57 0.0060
594 BLOOD GLUCOSE ABNORMAL 111 0.0060
595 SKIN EXFOLIATION 507 0.0060
596 COAGULOPATHY 100 0.0060
597 CARDIOGENIC SHOCK 86 0.0060
598 CONFUSIONAL STATE 968 0.0060
599 WOUND 167 0.0060
600 RESPIRATORY SYNCYTIAL VIRUS INFECTION 52 0.0060
601 HYPOCALCAEMIA 113 0.0060
602 HEMIPARESIS 101 0.0060
603 SKIN CANCER 128 0.0059
604 FUNGAL INFECTION 198 0.0059
605 NAUSEA 4684 0.0059
606 GASTROINTESTINAL INFECTION 53 0.0059
607 AMNESIA 384 0.0059
608 VISUAL IMPAIRMENT 731 0.0059
609 THROMBOSIS 474 0.0059
610 PULMONARY FIBROSIS 113 0.0059
611 PARAESTHESIA 926 0.0059
612 PRODUCT AVAILABILITY ISSUE 134 0.0059
613 PRODUCT DOSE OMISSION 384 0.0059
614 PRESYNCOPE 143 0.0059
615 RED BLOOD CELL SEDIMENTATION RATE INCREASED 65 0.0059
616 MASS 82 0.0059
617 DISORIENTATION 232 0.0058
618 HYPOACUSIS 252 0.0058
619 CEREBRAL INFARCTION 143 0.0058
620 CHROMATURIA 132 0.0058
621 JOINT STIFFNESS 153 0.0058
622 NO THERAPEUTIC RESPONSE 71 0.0058
623 ANXIETY 1649 0.0058
624 MOVEMENT DISORDER 186 0.0058
625 RASH 2524 0.0058
626 INTERNAL HAEMORRHAGE 66 0.0058
627 HYSTERECTOMY 50 0.0058
628 FLUID OVERLOAD 84 0.0058
629 PAIN 3541 0.0058
630 PARAESTHESIA ORAL 83 0.0057
631 GAIT INABILITY 192 0.0057
632 PARKINSONISM 56 0.0057
633 BACTERIAL INFECTION 107 0.0057
634 SWOLLEN TONGUE 179 0.0057
635 STAPHYLOCOCCAL INFECTION 189 0.0057
636 PRODUCT ODOUR ABNORMAL 60 0.0057
637 DEEP VEIN THROMBOSIS 372 0.0057
638 BACK INJURY 62 0.0057
639 ORAL CANDIDIASIS 75 0.0057
640 LOCAL SWELLING 99 0.0057
641 TREMOR 942 0.0057
642 MALAISE 2483 0.0057
643 GALLBLADDER DISORDER 101 0.0057
644 THERAPY INTERRUPTED 404 0.0056
645 LEUKOCYTOSIS 102 0.0056
646 ORAL HERPES 110 0.0056
647 URINARY RETENTION 188 0.0056
648 WEIGHT INCREASED 1259 0.0056
649 DISCOMFORT 343 0.0056
650 RASH GENERALISED 145 0.0056
651 LYMPHADENOPATHY 198 0.0056
652 QUALITY OF LIFE DECREASED 75 0.0056
653 LETHARGY 321 0.0056
654 ARTHROPATHY 309 0.0056
655 SPINAL PAIN 65 0.0055
656 DELUSION 86 0.0055
657 LUNG INFECTION 86 0.0055
658 PAIN OF SKIN 149 0.0055
659 RASH PAPULAR 124 0.0055
660 CHILLS 648 0.0055
661 PHARYNGEAL OEDEMA 85 0.0055
662 INJECTION SITE DISCOLOURATION 69 0.0055
663 ECZEMA 288 0.0055
664 LIVER DISORDER 244 0.0055
665 DEPRESSED MOOD 290 0.0055
666 MOBILITY DECREASED 392 0.0055
667 GASTROINTESTINAL PAIN 60 0.0054
668 INJECTION SITE NODULE 60 0.0054
669 HYPOAESTHESIA ORAL 82 0.0054
670 MUSCULOSKELETAL STIFFNESS 476 0.0054
671 PURPURA 48 0.0054
672 THERAPY NON-RESPONDER 243 0.0054
673 BLINDNESS 220 0.0054
674 SOMNOLENCE 1087 0.0054
675 NEOPLASM 62 0.0054
676 DERMATITIS 113 0.0054
677 PANCREATITIS 285 0.0054
678 ALOPECIA 1057 0.0054
679 ASPARTATE AMINOTRANSFERASE INCREASED 285 0.0054
680 CEREBRAL HAEMORRHAGE 192 0.0054
681 ABNORMAL DREAMS 148 0.0054
682 DRUG INTERACTION 847 0.0053
683 THERAPEUTIC RESPONSE UNEXPECTED 239 0.0053
684 RESPIRATORY DISTRESS 147 0.0053
685 ISCHAEMIC STROKE 95 0.0053
686 EYELID PTOSIS 54 0.0053
687 UROSEPSIS 49 0.0053
688 BODY TEMPERATURE DECREASED 52 0.0053
689 ULCER 84 0.0053
690 CANDIDA INFECTION 89 0.0053
691 SWELLING FACE 343 0.0053
692 BLOOD TEST ABNORMAL 74 0.0053
693 TENDON RUPTURE 65 0.0053
694 BRONCHOSPASM 75 0.0053
695 HEPATIC ENCEPHALOPATHY 49 0.0052
696 SEPSIS 584 0.0052
697 COORDINATION ABNORMAL 73 0.0052
698 INFECTION 757 0.0052
699 FACE OEDEMA 88 0.0052
700 DECREASED IMMUNE RESPONSIVENESS 51 0.0052
701 PERICARDITIS 87 0.0052
702 NEUTROPHIL COUNT INCREASED 53 0.0052
703 IMMUNODEFICIENCY 77 0.0052
704 CYST 64 0.0052
705 DISTURBANCE IN ATTENTION 278 0.0051
706 VISUAL ACUITY REDUCED 170 0.0051
707 PHARYNGEAL SWELLING 50 0.0051
708 SUBDURAL HAEMATOMA 73 0.0051
709 RASH ERYTHEMATOUS 243 0.0051
710 SPEECH DISORDER 266 0.0051
711 BLOOD BILIRUBIN INCREASED 137 0.0051
712 TUBULOINTERSTITIAL NEPHRITIS 95 0.0051
713 THROAT TIGHTNESS 137 0.0051
714 INFLAMMATION 261 0.0051
715 HEPATIC CIRRHOSIS 95 0.0051
716 THERAPEUTIC RESPONSE DECREASED 306 0.0050
717 PHARMACEUTICAL PRODUCT COMPLAINT 131 0.0050
718 ROAD TRAFFIC ACCIDENT 211 0.0050
719 SMALL INTESTINAL OBSTRUCTION 62 0.0050
720 LACTIC ACIDOSIS 163 0.0050
721 HIP ARTHROPLASTY 77 0.0050
722 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 117 0.0050
723 VOMITING 2354 0.0050
724 SINUS TACHYCARDIA 71 0.0050
725 DRUG EFFECT LESS THAN EXPECTED 74 0.0050
726 EYELID OEDEMA 58 0.0050
727 BLOOD LACTATE DEHYDROGENASE INCREASED 79 0.0050
728 FEMUR FRACTURE 154 0.0050
729 BREAST PAIN 53 0.0050
730 DYSARTHRIA 187 0.0050
731 HAEMATOCHEZIA 274 0.0050
732 GASTRIC HAEMORRHAGE 57 0.0049
733 HYPERSENSITIVITY 918 0.0049
734 COGNITIVE DISORDER 230 0.0049
735 SUDDEN DEATH 52 0.0049
736 COLON CANCER 73 0.0049
737 COELIAC DISEASE 48 0.0049
738 PNEUMONITIS 133 0.0049
739 PSORIATIC ARTHROPATHY 198 0.0049
740 ALANINE AMINOTRANSFERASE INCREASED 299 0.0049
741 SARS-COV-2 TEST POSITIVE 64 0.0048
742 PULMONARY EMBOLISM 460 0.0048
743 MIGRAINE 462 0.0048
744 IMPAIRED DRIVING ABILITY 55 0.0048
745 INJURY 340 0.0048
746 INFLUENZA LIKE ILLNESS 396 0.0048
747 IMMUNE SYSTEM DISORDER 63 0.0048
748 CARDIOVASCULAR DISORDER 121 0.0048
749 CLOSTRIDIUM DIFFICILE INFECTION 104 0.0048
750 PHARYNGITIS 59 0.0048
751 HUNGER 66 0.0047
752 WRONG TECHNIQUE IN DRUG USAGE PROCESS 172 0.0047
753 HEPATIC ENZYME INCREASED 322 0.0047
754 CONTRAINDICATED PRODUCT ADMINISTERED 143 0.0047
755 BEDRIDDEN 62 0.0047
756 TACHYCARDIA 419 0.0047
757 RESPIRATORY DISORDER 141 0.0047
758 APHASIA 142 0.0047
759 DYSKINESIA 191 0.0047
760 GASTROINTESTINAL DISORDER 421 0.0047
761 HAEMATEMESIS 119 0.0047
762 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 48 0.0047
763 ABDOMINAL PAIN 1085 0.0047
764 RESPIRATORY FAILURE 340 0.0047
765 SENSORY DISTURBANCE 74 0.0046
766 INCREASED APPETITE 88 0.0046
767 METASTASES TO LUNG 53 0.0046
768 ILEUS 57 0.0046
769 OBSTRUCTIVE AIRWAYS DISORDER 51 0.0046
770 CONDITION AGGRAVATED 1393 0.0046
771 PSORIASIS 598 0.0046
772 COVID-19 PNEUMONIA 54 0.0046
773 COLITIS 173 0.0046
774 MYELODYSPLASTIC SYNDROME 66 0.0046
775 HYPERTHYROIDISM 66 0.0046
776 METASTASES TO LIVER 80 0.0045
777 BACTERAEMIA 54 0.0045
778 ACTIVITIES OF DAILY LIVING IMPAIRED 90 0.0045
779 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 819 0.0045
780 LIVER FUNCTION TEST ABNORMAL 132 0.0045
781 METABOLIC ACIDOSIS 145 0.0045
782 CHOLECYSTITIS 54 0.0045
783 DERMATITIS ALLERGIC 57 0.0045
784 NIGHTMARE 156 0.0045
785 JAUNDICE 121 0.0045
786 HEPATITIS 115 0.0045
787 CARDIAC ARREST 371 0.0045
788 PULMONARY ARTERIAL HYPERTENSION 65 0.0045
789 MADAROSIS 52 0.0045
790 ASPIRATION 49 0.0045
791 CONJUNCTIVITIS 83 0.0045
792 PARALYSIS 64 0.0045
793 LYMPHOCYTE COUNT DECREASED 79 0.0045
794 ADVERSE EVENT 407 0.0044
795 HAEMORRHAGE INTRACRANIAL 66 0.0044
796 PRODUCT USE IN UNAPPROVED INDICATION 1094 0.0044
797 MALIGNANT MELANOMA 59 0.0044
798 PRODUCT ADMINISTRATION ERROR 89 0.0044
799 LYMPHOMA 68 0.0044
800 INTENTIONAL PRODUCT MISUSE 382 0.0044
801 PYREXIA 1504 0.0043
802 METASTASES TO BONE 71 0.0043
803 EXPOSURE VIA SKIN CONTACT 112 0.0043
804 TREATMENT NONCOMPLIANCE 236 0.0043
805 ADRENAL INSUFFICIENCY 52 0.0043
806 THERAPEUTIC RESPONSE SHORTENED 142 0.0043
807 DRUG INTOLERANCE 409 0.0042
808 ABDOMINAL PAIN LOWER 107 0.0042
809 UNRESPONSIVE TO STIMULI 109 0.0042
810 ASCITES 124 0.0042
811 PNEUMONIA ASPIRATION 105 0.0042
812 PALLOR 114 0.0042
813 ERYTHEMA 861 0.0042
814 PANCYTOPENIA 234 0.0042
815 INTENTIONAL PRODUCT USE ISSUE 366 0.0042
816 ADVERSE DRUG REACTION 375 0.0042
817 LIVER FUNCTION TEST INCREASED 89 0.0041
818 THINKING ABNORMAL 77 0.0041
819 TACHYPNOEA 56 0.0041
820 PRODUCT PHYSICAL ISSUE 83 0.0041
821 CIRCULATORY COLLAPSE 70 0.0041
822 MOUTH ULCERATION 86 0.0041
823 HOSPITALISATION 623 0.0041
824 FREQUENT BOWEL MOVEMENTS 109 0.0040
825 BODY TEMPERATURE INCREASED 82 0.0040
826 MUSCULOSKELETAL DISORDER 76 0.0040
827 EMOTIONAL DISORDER 123 0.0040
828 INTERSTITIAL LUNG DISEASE 193 0.0040
829 INJECTION SITE PRURITUS 266 0.0040
830 ILL-DEFINED DISORDER 241 0.0040
831 CYANOSIS 62 0.0039
832 IMPAIRED WORK ABILITY 83 0.0039
833 NEOPLASM PROGRESSION 135 0.0039
834 PANIC ATTACK 141 0.0039
835 HAEMORRHAGE 403 0.0039
836 DISABILITY 76 0.0038
837 DISSEMINATED INTRAVASCULAR COAGULATION 54 0.0038
838 RHEUMATOID ARTHRITIS 435 0.0038
839 URTICARIA 641 0.0038
840 PROCEDURAL PAIN 106 0.0038
841 THERAPEUTIC PRODUCT EFFECT DECREASED 171 0.0038
842 RESTLESSNESS 139 0.0038
843 INTESTINAL OBSTRUCTION 143 0.0038
844 SEPTIC SHOCK 165 0.0038
845 GAMMA-GLUTAMYLTRANSFERASE INCREASED 84 0.0038
846 CONVULSION 216 0.0038
847 PLASMA CELL MYELOMA 147 0.0038
848 FRACTURE 71 0.0037
849 CARDIO-RESPIRATORY ARREST 156 0.0037
850 OSTEONECROSIS OF JAW 92 0.0037
851 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 263 0.0037
852 PRODUCT USE ISSUE 691 0.0037
853 THROMBOCYTOPENIA 410 0.0037
854 APATHY 53 0.0036
855 TOOTH LOSS 75 0.0036
856 INJECTION SITE BRUISING 287 0.0036
857 PARANOIA 62 0.0036
858 ELECTROCARDIOGRAM QT PROLONGED 129 0.0036
859 NEOPLASM MALIGNANT 236 0.0035
860 DRUG TOXICITY 48 0.0035
861 INJECTION SITE RASH 108 0.0035
862 MOOD ALTERED 96 0.0035
863 INJECTION SITE PAIN 1077 0.0035
864 NEUTROPHIL COUNT DECREASED 142 0.0035
865 ENCEPHALOPATHY 85 0.0035
866 DRUG EFFECT DECREASED 186 0.0034
867 INJECTION SITE HAEMATOMA 50 0.0034
868 DEVICE RELATED INFECTION 53 0.0034
869 EOSINOPHILIA 60 0.0034
870 DIABETIC KETOACIDOSIS 82 0.0034
871 PRESCRIBED UNDERDOSE 68 0.0034
872 HEPATIC FUNCTION ABNORMAL 127 0.0034
873 MULTIPLE SCLEROSIS 162 0.0034
874 DRUG ERUPTION 60 0.0034
875 PRODUCT QUALITY ISSUE 457 0.0034
876 DRUG DOSE OMISSION 554 0.0033
877 AGITATION 246 0.0033
878 MULTIPLE FRACTURES 55 0.0033
879 DISEASE RECURRENCE 159 0.0033
880 CHOLESTASIS 64 0.0033
881 DRUG INEFFECTIVE 4390 0.0033
882 ALTERED STATE OF CONSCIOUSNESS 72 0.0033
883 DELIRIUM 115 0.0033
884 DISEASE PROGRESSION 386 0.0033
885 AGRANULOCYTOSIS 60 0.0032
886 SHOCK 74 0.0032
887 ANGER 108 0.0032
888 IRRITABILITY 192 0.0032
889 DEPRESSED LEVEL OF CONSCIOUSNESS 126 0.0032
890 ABNORMAL BEHAVIOUR 126 0.0032
891 PRODUCT PRESCRIBING ISSUE 69 0.0032
892 THERAPY CESSATION 162 0.0032
893 TRANSAMINASES INCREASED 70 0.0031
894 HALLUCINATION, AUDITORY 50 0.0031
895 INJECTION SITE SWELLING 241 0.0031
896 EMOTIONAL DISTRESS 380 0.0031
897 CRYING 113 0.0031
898 OSTEONECROSIS 102 0.0031
899 INJECTION SITE ERYTHEMA 385 0.0031
900 C-REACTIVE PROTEIN INCREASED 112 0.0031
901 THERAPY PARTIAL RESPONDER 48 0.0031
902 PRESCRIBED OVERDOSE 59 0.0030
903 OFF LABEL USE 2665 0.0030
904 LUNG NEOPLASM MALIGNANT 125 0.0030
905 MENTAL DISORDER 132 0.0030
906 DRUG ADMINISTRATION ERROR 93 0.0030
907 ANAPHYLACTIC SHOCK 78 0.0030
908 MEDICATION ERROR 168 0.0030
909 HEPATIC FAILURE 91 0.0030
910 ACCIDENTAL OVERDOSE 109 0.0030
911 GENERAL PHYSICAL HEALTH DETERIORATION 342 0.0030
912 DRUG EFFECT INCOMPLETE 107 0.0029
913 PERITONITIS 61 0.0029
914 MULTIPLE SCLEROSIS RELAPSE 201 0.0029
915 UNDERDOSE 214 0.0029
916 MENTAL IMPAIRMENT 71 0.0029
917 RASH MACULO-PAPULAR 64 0.0029
918 INJECTION SITE MASS 105 0.0028
919 INFUSION RELATED REACTION 188 0.0028
920 INCORRECT DOSE ADMINISTERED 646 0.0028
921 SYSTEMIC LUPUS ERYTHEMATOSUS 100 0.0028
922 INCORRECT DRUG ADMINISTRATION DURATION 79 0.0028
923 SEIZURE 322 0.0028
924 INJECTION SITE URTICARIA 68 0.0028
925 PRODUCT PRESCRIBING ERROR 66 0.0028
926 DEATH 2377 0.0028
927 PANCREATIC CARCINOMA 79 0.0027
928 NEEDLE ISSUE 79 0.0027
929 DRUG-INDUCED LIVER INJURY 85 0.0027
930 SUICIDAL IDEATION 247 0.0027
931 ANAPHYLACTIC REACTION 148 0.0027
932 INTENTIONAL DRUG MISUSE 56 0.0027
933 NERVOUS SYSTEM DISORDER 82 0.0026
934 COMA 125 0.0026
935 LOWER RESPIRATORY TRACT INFECTION 119 0.0026
936 STEVENS-JOHNSON SYNDROME 58 0.0026
937 APPLICATION SITE PRURITUS 58 0.0026
938 APPLICATION SITE ERYTHEMA 67 0.0026
939 BONE DENSITY DECREASED 80 0.0026
940 INJECTION SITE HAEMORRHAGE 203 0.0025
941 RESPIRATORY ARREST 70 0.0025
942 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 180 0.0025
943 MOOD SWINGS 80 0.0025
944 LIVER INJURY 61 0.0025
945 INJECTION SITE REACTION 167 0.0024
946 TARDIVE DYSKINESIA 68 0.0024
947 LEUKOPENIA 120 0.0024
948 BREAST CANCER FEMALE 64 0.0024
949 PRODUCT DISPENSING ERROR 52 0.0024
950 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 483 0.0024
951 SKIN IRRITATION 109 0.0024
952 MALIGNANT NEOPLASM PROGRESSION 243 0.0024
953 MUCOSAL INFLAMMATION 62 0.0024
954 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 129 0.0023
955 DRUG RESISTANCE 60 0.0023
956 NEUTROPENIA 309 0.0023
957 BREAST CANCER 211 0.0023
958 AGGRESSION 111 0.0022
959 VAGINAL HAEMORRHAGE 95 0.0022
960 FEBRILE NEUTROPENIA 144 0.0022
961 SEDATION 56 0.0021
962 NO ADVERSE EVENT 383 0.0021
963 DEVICE MALFUNCTION 148 0.0021
964 EXPIRED PRODUCT ADMINISTERED 70 0.0021
965 WITHDRAWAL SYNDROME 88 0.0021
966 MULTIPLE ORGAN DYSFUNCTION SYNDROME 59 0.0021
967 EXTRAPYRAMIDAL DISORDER 51 0.0021
968 SKIN BURNING SENSATION 144 0.0020
969 ACNE 152 0.0020
970 PSYCHOTIC DISORDER 59 0.0020
971 COLITIS ULCERATIVE 88 0.0020
972 ACCIDENTAL EXPOSURE TO PRODUCT 194 0.0019
973 EXTRA DOSE ADMINISTERED 74 0.0018
974 PROSTATE CANCER 145 0.0018
975 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 60 0.0018
976 DEVICE ISSUE 153 0.0017
977 OVERDOSE 355 0.0016
978 COMPLETED SUICIDE 126 0.0015
979 BLADDER CANCER 82 0.0014
980 DEVICE DISLOCATION 59 0.0014
981 SUICIDE ATTEMPT 82 0.0014
982 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 60 0.0013
983 DEVICE LEAKAGE 55 0.0013
984 TOXICITY TO VARIOUS AGENTS 211 0.0013
985 INTENTIONAL OVERDOSE 80 0.0012
986 DRUG WITHDRAWAL SYNDROME 98 0.0011
987 TREATMENT FAILURE 86 0.0010
988 PRODUCT STORAGE ERROR 80 0.0009
989 DEVICE DIFFICULT TO USE 54 0.0008
990 DRUG DOSE OMISSION BY DEVICE 59 0.0008
991 FOETAL EXPOSURE DURING PREGNANCY 58 0.0007
992 DRUG DEPENDENCE 67 0.0004